ScholarIQanswers from OpenAlex & ORCID
Rury R. Holman
ResearcherPublications, citations & collaboration network
Rury R. Holman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Rury R. Holman have?
ScholarIQindexed works
Rury R. Holman has 576 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Rury R. Holman have?
ScholarIQcitation count
Rury R. Holman has 62,632 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Rury R. Holman?
ScholarIQh-index
Rury R. Holman has an h-index of 99 in OpenAlex.
What is the i10-index of Rury R. Holman?
ScholarIQi10-index
Rury R. Holman has an i10-index of 304 in OpenAlex.
What is the ORCID of Rury R. Holman?
ScholarIQorcid
The ORCID for Rury R. Holman is on the source record.
What is the OpenAlex record for Rury R. Holman?
ScholarIQopenalex
The OpenAlex for Rury R. Holman is on the source record.
What are the most-cited papers on Rury R. Holman?
ScholarIQmost cited works
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, David R. Matthews, H. A. W. Neil
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
David M. Nathan, John B. Buse, Mayer B. Davidson, Ele Ferrannini, Rury R. Holman, Robert Sherwin, Bernard Zinman
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
Steven E. Kahn, Steven M. Haffner, Mark Heise, William H. Herman, Rury R. Holman, Nigel C. Jones, Barbara G. Kravitz, John M. Lachin, Mark O’Neill, Bernard Zinman, Giancarlo Viberti
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong, John B. Buse, Samuel S. Engel, Jyotsna Garg, Robert Josse, Keith D. Kaufman, Joerg Koglin, Scott Korn, John M. Lachin, Darren K. McGuire, Michael Pencina, Eberhard Standl, Peter P. Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D. Peterson, Rury R. Holman
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman, M. Angelyn Bethel, Robert J. Mentz, Vivian P. Thompson, Yuliya Lokhnygina, John B. Buse, Juliana C.N. Chan, Jasmine Choi, Stephanie M. Gustavson, Nayyar Iqbal, Aldo P. Maggioni, Steven P. Marso, Peter Öhman, Neha J. Pagidipati, Neil R Poulter, Ambady Ramachandran, Bernard Zinman, Adrian F. Hernandez